To order chemicals, medical devices, or other restricted products please provide ID that includes your business name & shipping address via email [email protected] or fax 484.881.5997 referencing your VWR account number. Acceptable forms of ID are:
- • State issued document with your organization's Federal Tax ID Number
- • State issued document with your organization's Resale Tax ID Number
- • City or County issued Business License
- • State Department of Health Services License
- • Any other ID issued by the State that includes the business name & address
* ATTN: California Customers may require additional documentation as part of the CA Health & Safety Code. Products that fall under this regulation will be placed on a mandatory 21-day hold after documentation is received. VWR will not lift restrictions for residential shipping addresses.
Spécifications
- Antibody type:Primary
- Antigen name:Zinc finger and BTB Domain containing 1
- Clonality:Polyclonal
- Gene ID:3459
- Host:Goat
- Isotype:IgG
- Neutralisation:Yes
- Reactivity:Human,Rat,Mouse
- Antigen symbol:ZBTB1
- Conjugation:Unconjugated
- ELISA:Yes
- Size:25μg
- Western blot:Yes
- Antigen synonyms:ZBTB1|Zinc finger and BTB domain-containing protein 1|KIAA0997|ZNF909
- Storage buffer:Preservative: NoneConstituents: PBS
- Storage temperature:Upon Receipt - Keep as concentrated solution. Aliquot and store at –20 °C or below. Avoid freeze-thaw cycles.
- Concentration:0.1mg/ml
- Immunogen:Purified recombinant human IFNGRI extracellular domain expressed in mouse NSO cells.
- Purification:Immunogen affinity purified
- Cat. no.:89285-978
- Supplier No.:GTX10745
Spécifications
A propos de cet article
Goat polyclonal to IFNGR1
ELISA: Use at a concentration of 0.5 - 1 ?g/ml. The detection limit for recombinant human IFNGRI is approximately 0.3 ng/well. Neut: Use at a concentration of 0.5 - 2 ?g/ml. WB: Use at a concentration of 0.1 - 0.2 ?g/ml. The detection limit for recombinant human IFNGRI is approximately 5 ng/lane under non-reducing and reducing conditions. Predicted molecular weight: 50 kDa. To measure the ability of this antibody to block the cell surface recombinant human IFNGRI mediated bioactivity on HeLa cells, various concentrations of the antibody are added to confluent cultures of HeLa cells in a 96 well plate. The assay mixture in a total volume of 150 ?l, containing antibody at concentrations from 0.01 to 50 ?g/ml, is incubated for 1 hour at 37 °C. Recombinant human IFNG is added at 2 ng/ml and the mixture is incubated at 37 °C for 20 to 24 hours in a humidified CO2 incubator. At the end of this incubation period, the medium is aspirated from the wells and a titrated amount of Encephalomyocarditis virus (EMCV) in prewarmed culture medium is added to each test well. After an additional 20 to 24 hour incubation period, the cells are fixed, stained, and scored for cytopathic effect by measurement of optical densities in a microplate reader at 540 nm. The Neutralization Dose50 (ND50) for anti-human IFNG receptor I is approximately 0.5 to 2.0 ?g/ml in the presence of 2 ng/ml of recombinant human IFNG, using a confluent culture of HeLa cells. The ND50 is the concentration of antibody required to yield one-half maximal inhibition of the cytokine activity on a responsive cell line, when the cytokine is present at a concentration just high enough to elicit a maximum response. The exact concentration of antibody required to neutralize recombinant human IFNGRI activity is dependent on the cytokine concentration, cell type, growth conditions, and the type of activity studied. Not tested in other applications. Optimal dilutions/concentrations should be determined by the end user.
Type: Primary
Antigen: ZBTB1
Clonality: Polyclonal
Clone:
Conjugation:
Epitope:
Host: Goat
Isotype:
Reactivity: Human, Mouse, Rat